CLINICAL RESEARCH
Penetrance of Mutations in Plakophilin-2 Among Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Darshan Dalal, MD, MPH*,
Cynthia James, ScM, PhD*,
Rajiv Devanagondi, BA*,
Crystal Tichnell, MGC*,
April Tucker, MGC*,
Kalpana Prakasa, MD*,
Philip J. Spevak, MD, FACC ,
David A. Bluemke, MD, PhD*, ,
Theodore Abraham, MD, FACC*,
Stuart D. Russell, MD, FACC*,
Hugh Calkins, MD, FACC* and
Daniel P. Judge, MD*,*
* Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Division of Cardiology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Manuscript received March 20, 2006;
revised manuscript received May 9, 2006,
accepted June 6, 2006.
* Reprint requests and correspondence: Dr. Daniel Judge, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 1049, Baltimore, Maryland 21205. (Email: djudge{at}jhmi.edu).
OBJECTIVES: The purpose of our study was to characterize the penetrance of PKP2 mutations among family members of people with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and to examine clinical features and predictors of disease among PKP2 mutation carriers.
BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy characterized by fatty-fibrous myocardial replacement of the right ventricle, ventricular arrhythmias, and right ventricular dysfunction. Mutations in PKP2, the gene encoding plakophilin-2, are found in 11% to 43% of ARVD/C probands.
METHODS: The study population was composed of 64 individuals in 9 families with an ARVD/C proband previously shown to carry a pathogenic PKP2 mutation. The diagnosis of ARVD/C was established based on task force criteria (TFC) set by the European Society of Cardiology.
RESULTS: In addition to the probands, PKP2 mutations were present in 52% of relatives screened. Forty-nine percent of PKP2 mutation carriers met TFC. Among mutation carriers who did not meet full TFC, 50% met at least some TFC criteria besides family history. Pedigrees showed wide intra-familial variability, ranging from severe disease with early death to individuals who were completely asymptomatic late in life. Male PKP2 mutation carriers were more likely to have structural and conduction abnormalities as determined by imaging studies, signal-averaged electrocardiography, and 24-h ambulatory electrocardiography (p < 0.05).
CONCLUSIONS: PKP2 mutations in a group of North American families with ARVD/C have both reduced penetrance and variable expressivity. Gender may have an influence on penetrance of PKP2 mutations, with male mutation carriers more likely to develop specific phenotypic manifestations of this disease.
|
Abbreviations and Acronyms
| | ARVD/C = arrhythmogenic right ventricular dysplasia/cardiomyopathy | | DNA = deoxyribonucleic acid | | ECG = electrocardiogram | | ICD = implantable cardioverter-defibrillator | | RV = right ventricle/ventricular | | SAECG = signal-averaged electrocardiogram | | TFC = task force criteria (for diagnosis of ARVD/C) | | VT = ventricular tachycardia |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Ackerman, S. G. Priori, S. Willems, C. Berul, R. Brugada, H. Calkins, A. J. Camm, P. T. Ellinor, M. Gollob, R. Hamilton, et al.
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Europace,
August 1, 2011;
13(8):
1077 - 1109.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Judge
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Family Affair
Circulation,
June 14, 2011;
123(23):
2661 - 2663.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. P. J. Cox, P. A. van der Zwaag, C. van der Werf, J. J. van der Smagt, M. Noorman, Z. A. Bhuiyan, A. C. P. Wiesfeld, P. G. A. Volders, I. M. van Langen, D. E. Atsma, et al.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study
Circulation,
June 14, 2011;
123(23):
2690 - 2700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Sarvari, K. H. Haugaa, O.-G. Anfinsen, T. P. Leren, O. A. Smiseth, E. Kongsgaard, J. P. Amlie, and T. Edvardsen
Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction
Eur. Heart J.,
May 1, 2011;
32(9):
1089 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Charron, M. Arad, E. Arbustini, C. Basso, Z. Bilinska, P. Elliott, T. Helio, A. Keren, W. J. McKenna, L. Monserrat, et al.
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Eur. Heart J.,
November 2, 2010;
31(22):
2715 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Raman, C. Basso, H. Tandri, and M. R. G. Taylor
Imaging Phenotype vs Genotype in Nonhypertrophic Heritable Cardiomyopathies: Dilated Cardiomyopathy and Arrhythmogenic Right Ventricular Cardiomyopathy
Circ Cardiovasc Imaging,
November 1, 2010;
3(6):
753 - 765.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Delmar and W. J. McKenna
The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies: From Gene to Disease
Circ. Res.,
September 17, 2010;
107(6):
700 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sen-Chowdhry, P. Syrris, A. Pantazis, G. Quarta, W. J. McKenna, and J. C. Chambers
Mutational Heterogeneity, Modifier Genes, and Environmental Influences Contribute to Phenotypic Diversity of Arrhythmogenic Cardiomyopathy
Circ Cardiovasc Genet,
August 1, 2010;
3(4):
323 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. P. J. Cox, J. J. van der Smagt, M. Noorman, A. C. Wiesfeld, P. G. A. Volders, I. M. van Langen, D. E. Atsma, D. Dooijes, A. C. Houweling, P. Loh, et al.
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria: Impact of New Task Force Criteria
Circ Arrhythm Electrophysiol,
April 1, 2010;
3(2):
126 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Xu, Z. Yang, M. Vatta, A. Rampazzo, G. Beffagna, K. Pillichou, S. E. Scherer, J. Saffitz, J. Kravitz, W. Zareba, et al.
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy
J. Am. Coll. Cardiol.,
February 9, 2010;
55(6):
587 - 597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. den Haan, B. Y. Tan, M. N. Zikusoka, L. I. Llado, R. Jain, A. Daly, C. Tichnell, C. James, N. Amat-Alarcon, T. Abraham, et al.
Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Circ Cardiovasc Genet,
October 1, 2009;
2(5):
428 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al.
Morphologic Variants of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Genetics-Magnetic Resonance Imaging Correlation Study
J. Am. Coll. Cardiol.,
April 14, 2009;
53(15):
1289 - 1299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Qian, B. Mohapatra, T. Akasaka, J. Liu, K. Ocorr, J. A. Towbin, and R. Bodmer
Transcription factor neuromancer/TBX20 is required for cardiac function in Drosophila with implications for human heart disease
PNAS,
December 16, 2008;
105(50):
19833 - 19838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna
Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol.,
November 6, 2007;
50(19):
1813 - 1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Judge, N. M. Johnson, A. L. Cirino, and C. Y. Ho
Heart Failure and Genomics
J. Am. Coll. Cardiol.,
March 13, 2007;
49(10):
1106 - 1106.
[Full Text]
[PDF]
|
 |
|
|